Red Flags in Clinical Lab Operations Rise from Recent Court Cases
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Guilty plea points to patient data collection, while settlement implicates an undisclosed relationship
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Hologic has been on the vanguard of developing and distributing tests focusing on women’s health
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history
In both cases, the diagnostic tests report results back within 15 minutes
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
The national lab giant swiftly merged Empire City’s operations into its own
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns